Baicalein, a Natural Anti-Cancer Compound, Alters MicroRNA Expression Profiles in Bel-7402 Human Hepatocellular Carcinoma Cells | Zendy

Beibei Bie | Zendy; Jin Sun | Zendy; Jun Li | Zendy; Ying Guo | Zendy; Wei Jiang | Zendy; Chen Huang | Zendy; Jun Yang | Zendy; Zongfang Li | Zendy

Open Access

Baicalein, a Natural Anti-Cancer Compound, Alters MicroRNA Expression Profiles in Bel-7402 Human Hepatocellular Carcinoma Cells

Author(s) -

Beibei Bie,

Jin Sun,

Jun Li,

Ying Guo,

Wei Jiang,

Chen Huang,

Jun Yang,

Zongfang Li

Publication year - 2017

Publication title -

cellular physiology and biochemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.486

H-Index - 87

eISSN - 1421-9778

pISSN - 1015-8987

DOI - 10.1159/000470815

Subject(s) - baicalein , cell growth , pi3k/akt/mtor pathway , microrna , cell cycle , protein kinase b , cancer research , wnt signaling pathway , cell culture , biology , microbiology and biotechnology , cell , chemistry , signal transduction , pharmacology , gene , biochemistry , genetics

Baicalein has been shown to possess significant anti-hepatoma activity by inhibiting cell proliferation. Whether the anti-proliferative effect of baicalein is related to its modulation of miRNA expression in hepatocellular carcinoma (HCC) is still unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research